SRNEQ - Sorrento Therapeutics, Inc.

QQQ $ 490.95 $ 4.06 (0.83 %)

DIA $ 392.84 $ -0.46 (-0.12 %)

SPY $ 551.46 $ 2.45 (0.45 %)

TLT $ 91.86 $ 1.19 (1.31 %)

GLD $ 217.99 $ 2.43 (1.13 %)

Previous Close

$ 0.033

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.00 - $ 0.42

Volume

1,981,522

Average Volume

Market Cap

18.19M

Beta (5Y Monthly)

$ -1.23

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2023	06-30-2023	10-Q
2	05-15-2023	03-31-2023	10-Q
3	03-16-2023	12-31-2022	10-K
4	11-08-2022	09-30-2022	10-Q
5	08-15-2022	06-30-2022	10-Q
6	05-05-2022	03-31-2022	10-Q
7	03-11-2022	12-31-2021	10-K
8	11-05-2021	09-30-2021	10-Q
9	08-06-2021	06-30-2021	10-Q
10	05-05-2021	03-31-2021	10-Q
11	02-19-2021	12-31-2020	10-K
12	11-09-2020	09-30-2020	10-Q
13	08-04-2020	06-30-2020	10-Q
14	05-11-2020	03-31-2020	10-Q
15	03-03-2020	12-31-2019	10-K
16	11-12-2019	09-30-2019	10-Q
17	08-09-2019	06-30-2019	10-Q
18	05-15-2019	03-31-2019	10-Q
19	03-15-2019	12-31-2018	10-K
20	11-09-2018	09-30-2018	10-Q
21	08-09-2018	06-30-2018	10-Q
22	05-10-2018	03-31-2018	10-Q
23	03-16-2018	12-31-2017	10-K
24	11-09-2017	09-30-2017	10-Q
25	08-09-2017	06-30-2017	10-Q
26	05-15-2017	03-31-2017	10-Q
27	03-22-2017	12-31-2016	10-K
28	11-09-2016	09-30-2016	10-Q
29	08-08-2016	06-30-2016	10-Q
30	05-10-2016	03-31-2016	10-Q
31	03-15-2016	12-31-2015	10-K
32	11-16-2015	09-30-2015	10-Q
33	08-07-2015	06-30-2015	10-Q
34	05-05-2015	03-31-2015	10-Q
35	03-16-2015	12-31-2014	10-K
36	11-04-2014	09-30-2014	10-Q
37	08-06-2014	06-30-2014	10-Q
38	05-14-2014	03-31-2014	10-Q
39	04-01-2014	12-31-2013	10-K
40	11-14-2013	09-30-2013	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Reported Earlier, Scilex Announces Move To...
03/04/2024 06:55:28

- Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))), an innovative revenue-generating company focused on acquiring,...

Virpax Pharmaceuticals Announces Proposed ...
02/27/2024 12:43:11

As part of the settlement, the parties have agreed to a cash payment from Virpax to the Plaintiffs of $3.5 million by March 1, ...

Scilex Holding Company Provides Notice To ...
10/03/2023 13:11:42

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focuse...

Scilex Assumed $100M In Debt Owed To Orame...
09/21/2023 20:15:08

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focuse...

Scilex Holding Company Announces The Consu...
09/21/2023 20:15:06

Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focuse...

Sorrento Therapeutics, Inc. Announces Auct...
08/08/2023 14:04:52

Sorrento Therapeutics, Inc. (OTC:SRNEQ, ", , Sorrento", , or ", , the Debtor", , )))), a biopharmaceutical comp...

Sorrento Announces Launch Of Voluntary Off...
07/21/2023 13:01:54

In connection with its ongoing chapter 11 case, Sorrento Therapeutics, Inc. (OTC:SRNEQ, ", , Sorrento", , )))), a biop...

Sorrento Therapeutics, Inc.'s Bankruptcy C...
07/20/2023 13:03:35

Sorrento Therapeutics, Inc. (OTC:SRNEQ, ", , Sorrento", , )))), a biopharmaceutical company dedicated to the developme...

Scilex Holding Company Announces That Sorr...
06/15/2023 13:05:07

Scilex Holding Company (NASDAQ:SCLX, "Scilex")))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC:SRNE...

Scilex Holding Company Provides Certain Pr...
06/01/2023 16:31:08

Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC:...

Scilex Holding Company Enters Master Distr...
05/31/2023 19:26:59

Designated Territories will include Kingdom of Saudi Arabia. CH Trading Group will continue the process to expand comm...

Scilex Holding Company Added To The Prelim...
05/22/2023 13:13:38

Scilex Holding Company (NASDAQ:SCLX, "Scilex")))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC:SRNE...

Sorrento Therapeutics Bankruptcy Court Ord...
05/14/2023 23:23:42

Sorrento Therapeutics, Inc. (OTC:SRNEQ, ", Sorrento", )), a biopharmaceutical company dedicated to the development of l...

Scilex Holding Company Announces Complete ...
05/04/2023 13:03:27

Scilex Holding Company, an innovative revenue-generating company focused on acquiring, developing and commercializing non-opi...

Scilex Holding Co Announces That Its Major...
04/26/2023 12:02:16

Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))) announced that its majority stockholder, Sorrento Therapeutics, I...

scilex-inks-distribution-agreement-for-neuropathic-painkiller-ztlido-in-the-middle-east-and-north-africa

Scilex Inks Distribution Agreement For Neu...
04/17/2023 14:44:35

Scilex Holding Company Enters Into Master ...
04/17/2023 13:13:45

Designated Territories will include the United Arab Emirates, Qatar, Bahrain, Kuwait, Oman, and Egypt. CH Trading Group L...

Scilex Holding Company And CH Trading Grou...
03/08/2023 15:14:46

CH Trading Group will serve as exclusive territories distributor in the Middle East and North Africa countries with US $105 m...

Scilex Holding Company Announces The Comme...
02/27/2023 14:09:40

ELYXYBTM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine,...

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Cambium Networks Corporation (CMBM)

07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

SRNEQSorrento Therapeutics, Inc.

OTC sorrentotherapeutics.com

$ 0.00 (10 %)